CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-16 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion | +2,805 | 86,519 | ||
| 2016-05-16 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion | +7,698 | 94,217 | ||
| 2016-05-16 | MCGRATH JOHN Chief Financial Officer | Sale | −5,395 | $15.77 | $85K | 88,822 |
| 2016-05-16 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,805 | 9,348 | ||
| 2016-05-16 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −7,698 | 51,316 | ||
| 2016-05-16 | Haqq Christopher Chief Medical Officer | Exercise or conversion | +830 | 296,070 | ||
| 2016-05-16 | Haqq Christopher Chief Medical Officer | Sale | −1,605 | $15.57 | $25K | 294,465 |
| 2016-05-16 | Haqq Christopher Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −830 | 5,527 | ||
| 2016-05-16 | Fust Matthew K Director | Exercise or conversion | +1,602 | 13,888 | ||
| 2016-05-16 | Fust Matthew K Director | Exercise or conversion · Restricted Stock Units | −1,602 | 11,752 | ||
| 2016-05-16 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion | +7,212 | 87,912 | ||
| 2016-05-16 | Clark Mitchall G. Chief R & QA Officer | Sale | −4,153 | $15.15 | $63K | 83,759 |
| 2016-05-16 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion · Restricted Stock Unites | −7,212 | 55,288 | ||
| 2016-05-16 | Ciechanover Isaac E. Chief Executive Officer | Exercise or conversion | +5,907 | 223,228 | ||
| 2016-05-16 | Ciechanover Isaac E. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −5,907 | 39,385 | ||
| 2016-04-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −100 | $20.15 | $2K | 363,511 |
| 2016-04-25 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,200 | $20.12 | $24K | 363,611 |
| 2016-04-12 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,200 | $20.20 | $24K | 364,811 |
| 2016-04-11 | Ciechanover Isaac E. Chief Executive Officer | Sale | −12,010 | $20.42 | $245K | 366,011 |
| 2016-04-01 | Ciechanover Isaac E. Chief Executive Officer | Sale | −890 | $20.04 | $18K | 378,021 |
Page 54 of 71 · 1,403 trades